These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2263199)

  • 1. The inclusion of an assay for inherited congenital malformations in the assessment of mutagenicity.
    Douglas GR
    Mutagenesis; 1990 Sep; 5(5):421-3. PubMed ID: 2263199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenerational transmission of radiation- and chemically induced tumors and congenital anomalies in mice: studies of their possible relationship to induced chromosomal and molecular changes.
    Nomura T; Nakajima H; Ryo H; Li LY; Fukudome Y; Adachi S; Gotoh H; Tanaka H
    Cytogenet Genome Res; 2004; 104(1-4):252-60. PubMed ID: 15162048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on X-ray and chemically induced germ-line alterations causing tumors and malformations in mice.
    Normura T
    Prog Clin Biol Res; 1986; 209B():13-20. PubMed ID: 3749073
    [No Abstract]   [Full Text] [Related]  

  • 4. [The necessity of determining the mutagenicity of new drugs].
    Bogajewski J; Schöneich J
    Pol Tyg Lek; 1982 Mar; 37(2):63-7. PubMed ID: 6750579
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical, genetic and regulatory consequences of exposure to mutagens.
    Rüdiger HW
    Ann Genet; 1991; 34(3-4):173-8. PubMed ID: 1809224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced chromosomal aberrations and associated congenital malformations in rats.
    Saxena AK; Singh G
    In Vitro Cell Dev Biol Anim; 1998; 34(10):751-2. PubMed ID: 9870522
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for the testing of chemical for mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1981; 24():1-95. PubMed ID: 7244358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Congenital developmental defects in children and environmental pollution].
    Reznik BIa; Minkov IP; Kriven'kaia MN; Prudkiĭ VIa; Kil'dyshova AN; Minervina SS
    Pediatriia; 1991; (12):37-41. PubMed ID: 1788019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation as a mutagen.
    Finley WH
    Ala J Med Sci; 1988 Oct; 25(4):456-9. PubMed ID: 3218697
    [No Abstract]   [Full Text] [Related]  

  • 10. Reducing the incidence of congenital malformations through mutagenesis risk assessment: considerations for future research.
    Bishop JB
    Prog Clin Biol Res; 1985; 163C():409-13. PubMed ID: 3991652
    [No Abstract]   [Full Text] [Related]  

  • 11. Transgenerational effects from exposure to environmental toxic substances.
    Nomura T
    Mutat Res; 2008; 659(1-2):185-93. PubMed ID: 18406661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomy in man.
    Hassold TJ; Jacobs PA
    Annu Rev Genet; 1984; 18():69-97. PubMed ID: 6241455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two chromosome aberrations in the child of a woman with systemic lupus erythematosus treated with azathioprine and prednisone.
    Ostrer H; Stamberg J; Perinchief P
    Am J Med Genet; 1984 Mar; 17(3):627-32. PubMed ID: 6711614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-teratogen interactions in chemically induced congenital malformations.
    Giavini E; Menegola E
    Biol Neonate; 2004; 85(2):73-81. PubMed ID: 14631152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in genetics. Congenital malformations.
    Holmes LB
    N Engl J Med; 1976 Jul; 295(4):204-7. PubMed ID: 1272350
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mutagenicity tests for isepamicin (HAPA-B)].
    Sono A; Oyaide K; Kobayashi Y; Yamamoto H
    Jpn J Antibiot; 1986 Dec; 39(12):3341-8. PubMed ID: 3560443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes.
    Cimino MC
    Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk estimation for multifactorial diseases. A report of the International Commission on Radiological Protection.
    Ann ICRP; 1999; 29(3-4):1-144. PubMed ID: 11108911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity assessment of acrylate and methacrylate compounds and implications for regulatory toxicology requirements.
    Johannsen FR; Vogt B; Waite M; Deskin R
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):322-35. PubMed ID: 18346829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.